Business Units
Active Pharmaceutical Ingredients
API development, manufacture and generics supply
Formulation Development
Formulation development, analytics and GMP services
Finished Dose
Contract manufacturing and packaging expertise
Latest news
-
Canaland provides a full high potent service – drug development through to commercial covering both API and drug product manufacturing
8th October 2014
-
Canaland provides a full controlled drugs service from development through to commercial scale supply – handling both API and drug product manufacturing of scheduled drugs
7th October 2014
-
Consort Medical plc announces the proposed acquisition of Canaland Pharmaceuticals Limited for £230 million
30th September 2014